NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. Its products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. The company also provides telemedicine equipment.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $245.3M | $252.8M | $277.2M | $259.0M | $254.4M | $249.3M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$227.4M | -$179.1M | -$275.9M | -$692.1M | -$217.5M | -$105.3M |
| Net income | -$224.4M | -$176.3M | -$270.4M | -$675.2M | -$208.1M | -$95.7M |
| Diluted EPS | -$2.27 | -$0.69 | -$19.72 | -$47.50 | -$13.88 | -$5.96 |
| Operating cash flow | -$112.5M | -$141.5M | -$192.3M | -$148.3M | -$127.3M | -$66.0M |
| Free cash flow | -$115.8M | -$142.1M | -$192.6M | -$148.5M | -$127.5M | -$66.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -92.7% | -70.9% | -99.5% | -267.2% | -85.5% | -42.2% |
| Net margin | -91.5% | -69.8% | -97.6% | -260.6% | -81.8% | -38.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $62.8M | $61.0M | $71.0M | $66.8M | $70.9M | $56.3M | $55.3M | $54.9M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$52.4M | -$47.4M | -$42.8M | -$30.4M | -$20.4M | -$29.3M | -$25.2M | -$17.4M |
| Net income | -$49.9M | -$43.5M | -$42.7M | -$18.7M | -$19.7M | -$32.4M | -$24.9M | -$10.9M |
| Diluted EPS | -$3.36 | -$2.87 | -$2.71 | -$1.19 | -$1.24 | -$2.00 | -$1.53 | -$0.66 |
| Operating cash flow | -$21.8M | -$32.4M | -$13.4M | -$25.1M | -$4.7M | -$18.8M | -$17.4M | -$983,000.00 |
| Free cash flow | -$21.8M | -$32.4M | -$13.4M | -$25.1M | -$4.7M | -$18.8M | -$17.4M | -$988,000.00 |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -83.4% | -77.6% | -60.2% | -45.5% | -28.7% | -52.1% | -45.5% | -31.7% |
| Net margin | -79.5% | -71.2% | -60.1% | -28.0% | -27.8% | -57.5% | -45.1% | -19.8% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Zamansky Dmitry· Chief Product & Tech. Officer | Sale | 8,460 | $9.33 | $78,931.80 | filing |
| 2026-07-01 | Gotlib Phyllis· President, International | Sale | 6,677 | $9.33 | $62,296.41 | filing |
| 2026-07-01 | HIRSCHHORN MARK· Chief Financial Officer | Sale | 4,299 | $9.33 | $40,109.67 | filing |
| 2026-07-01 | McNeice Paul Francis· Chief Accounting Officer | Sale | 653 | $9.33 | $6,092.49 | filing |
| 2026-06-16 | Schlegel Stephen J. | Award | 14,501 | $0.00 | $0.00 | filing |
| 2026-06-16 | Jackson Deborah C | Award | 14,501 | $0.00 | $0.00 | filing |
| 2026-06-16 | Ross Derek | Award | 14,501 | $0.00 | $0.00 | filing |
| 2026-06-16 | Cosgrove Delos M. | Award | 14,501 | $0.00 | $0.00 | filing |
| 2026-06-16 | Webb Robert Thomas | Award | 14,501 | $0.00 | $0.00 | filing |
| 2026-06-16 | Goldwasser Rivka | Award | 14,501 | $0.00 | $0.00 | filing |
| 2026-06-11 | Schlegel Stephen J. | Sale | 9,750 | $8.76 | $85,449.00 | filing |
| 2026-06-01 | HIRSCHHORN MARK· Chief Financial Officer | Sale | 10,761 | $9.74 | $104,812.14 | filing |
| 2026-06-01 | Gotlib Phyllis· President, International | Sale | 3,573 | $9.74 | $34,801.02 | filing |
| 2026-06-01 | McNeice Paul Francis· Chief Accounting Officer | Sale | 112 | $9.74 | $1,090.88 | filing |
| 2026-05-07 | Schoenberg Ido· Chairman, co-CEO | Buy | 670 | $7.37 | $4,937.90 | filing |
| 2026-04-01 | Zamansky Dmitry· Chief Product & Tech. Officer | Sale | 5,575 | $5.30 | $29,547.50 | filing |
| 2026-04-01 | Gotlib Phyllis· President, International | Sale | 3,706 | $5.30 | $19,641.80 | filing |
| 2026-04-01 | McNeice Paul Francis· Chief Accounting Officer | Sale | 383 | $5.30 | $2,029.90 | filing |
| 2026-03-04 | Zamansky Dmitry· Chief Product & Tech. Officer | Award | 50,413 | $0.00 | $0.00 | filing |
| 2026-03-04 | HIRSCHHORN MARK· Chief Financial Officer | Award | 50,413 | $0.00 | $0.00 | filing |
| 2026-03-04 | Gotlib Phyllis· President, International | Award | 50,413 | $0.00 | $0.00 | filing |
| 2026-03-04 | McNeice Paul Francis· Chief Accounting Officer | Award | 8,066 | $0.00 | $0.00 | filing |
| 2026-03-02 | HIRSCHHORN MARK· Chief Financial Officer | Sale | 10,796 | $5.24 | $56,571.04 | filing |
| 2026-03-02 | Gotlib Phyllis· President, International | Sale | 3,573 | $5.24 | $18,722.52 | filing |
| 2026-03-02 | Zamansky Dmitry· Chief Product & Tech. Officer | Sale | 2,472 | $5.45 | $13,472.40 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.